New Nordic Healthbrands AB Logo

New Nordic Healthbrands AB

NNH | ST

Overview

Corporate Details

ISIN(s):
SE0001838038
LEI:
213800JGTLNSKRD49G44
Country:
Sweden
Address:
SÖDRA FÖRSTADSGATAN 3, 211 43 MALMÖ
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

New Nordic Healthbrands AB is a company specializing in the development, marketing, and sale of herbal dietary supplements, natural remedies, and beauty products. Founded in 1990, the company's mission is to promote healthier living through innovative, natural products. Its portfolio includes a wide range of food supplements and personal care items. New Nordic emphasizes its unique expertise in medicinal plants and maintains a strong focus on research and development. The company ensures the safety and effectiveness of its products through controlled laboratory analysis and extensive trials, operating on a global scale with a presence in numerous countries across Europe, North America, Asia, and Australia.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for New Nordic Healthbrands AB. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all New Nordic Healthbrands AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for New Nordic Healthbrands AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2021-09-10 Karl Kristian Bergman Jensen Other Sell 22 2,255.00 SEK
2021-09-10 Karl Kristian Bergman Jensen Other Sell 53 5,406.00 SEK
2021-09-10 Karl Kristian Bergman Jensen Other Sell 470 49,115.00 SEK
2021-09-10 Karl Kristian Bergman Jensen Other Sell 142 15,052.00 SEK
2021-09-10 Karl Kristian Bergman Jensen Other Sell 300 31,200.00 SEK

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK